Page 1

Press Release For Immediate Distribution SUNWAY HEALTHCARE SUNWAY HEALTHCARE DELIVERS SOLID SECOND QUARTER GROWTH WITH REVENUE UP 30 % AND PROFIT AFTER TAX NEARLY DOUBLING Revenue rises 30 % year - on - year supported by higher patient volumes , improved bed occupancy and stronger hospital activities ; reported EBITDA climbs 43 % and profit after tax jumps 89 % 20 August 2026 , KUALA LUMPUR - Sunway Healthcare Holdings Berhad ( " SHH " or the " Group " ) , one of Malaysia's leading integrated private healthcare providers , today announced its financial results for the second quarter and six - month ended 30 June 2026 ( " Q2FY2026 " and " H1FY2026 " , respectively ) . The Group delivered record quarterly revenue and stronger earnings in Q2FY2026 , reflecting progressive capacity activation , higher patient volumes and improving operating leverage across its hospital network . Key Financial and Operating Highlights ( Q2FY2026 ) • • • Total licensed beds expanded by 13 % year - on - year ( " y - o - y ” ) to 1,855 beds . As at 30 June 2026 , the Group had total bed capacity of 2,072 beds , providing further headroom for near - term growth . Revenue rose 30 % y - o - y to a record RM672.9 million ( Q2FY2025 : RM518.6 million ) , driven primarily by stronger patient volumes across the Group's hospital network and robust revenue contributions from Sunway Medical Centre ( " SMC " ) Sunway City , SMC Damansara and SMC Ipoh . Bed occupancy rate rose to 73 % ( Q2FY2025 : 67 % ) , as inpatient admissions increased by 19 % y- o - y to 32,599 , supported by 208 additional licensed beds y - o - y and improved utilisation at SMC Damansara and SMC Ipoh . Revenue per inpatient admission grew 8 % y - o - y to RM12,515 ( Q2FY2025 : RM11,587 ) . • Reported EBITDA increased 43 % y - o - y to RM158.8 million ( Q2FY2025 : RM111.2 million ) , with earnings growth outpacing revenue growth as higher patient volumes and improved utilisation supported stronger operating leverage across the hospital network . EBITDA margin correspondingly strengthened by 2.2 percentage points to 23.6 % ( Q2FY2025 : 21.4 % ) . • • • Excluding non - recurring costs , normalised EBITDA ( 1 ) rose 44 % y - o - y to RM161.3 million ( Q2FY2025 : RM112.2 million ) , with adjusted EBITDA margin expanding by 2.4 ppts to 24.0 % ( Q2FY2025 : 21.6 % ) , reflecting the improvement in the Group's underlying operating performance . Profit attributable to owners of the Company increased 89 % y - o - y to RM78.2 million ( Q2FY2025 : RM41.4 million ) , underpinned by stronger operating performance , notwithstanding higher depreciation from the expanded asset base . Net gearing ratio improved significantly from 42 % ( 31 December 2025 ) to 10 % ( 30 June 2026 ) following the Group's IPO . Note : ( 1 ) Normalised EBITDA is a non - MFRS financial measure and is presented to provide additional insight into the Group's underlying operating performance . It is not a substitute for EBITDA or profit measures prepared under MFRS .